Categories
Market & Economy News

EU Regulator Begins Review of Pfizer’s COVID-19 Pill

The European Union’s drug regulator is reviewing data on Pfizer’s COVID-19 pill to help member states decide on quick adoption ahead of any formal EU-wide approval, it said https://www.ema.europa.eu/en/news/ema-starts-review-paxlovid-treating-patients-covid-19 on Friday, days after the drugmaker sought U.S. authorisation. Read More